描述
Product Specifications
Attribute | Details |
---|---|
Product Name | Vardenafil Hydrochloride Tablets (Guan’ai® / Qing Doctor) |
Generic Name | Vardenafil Hydrochloride |
CAS Number | 224785?90?4 (free base) / 330808?88?3 (HCl trihydrate) access.portico.org+12en.wikipedia.org+12accessdata.fda.gov+12 |
Molecular Formula | C??H??N?O?S · HCl · 3H?O (trihydrate) |
Molecular Weight | ~579.1?g/mol (trihydrate) |
Dosage Form | Film-coated oral tablet |
Strength | 20?mg per tablet |
Pack Size | 5 tablets per box (1 blister pack) |
Approval No. | China NMPA H20244792 |
Product Code | 86904339000956 |
Manufacturer | Anhui Pioneer Pharmaceutical Co., Ltd. |
Barcode | 6953780000446 |
Storage | Store at 15–25?°C; protect from light and moisture |
Intended Use | Laboratory/preclinical research only |
Mechanism of Action
Vardenafil selectively inhibits PDE5, preventing cGMP breakdown and amplifying nitric oxide-mediated smooth muscle relaxation—primarily in penile and vascular tissues .
Research Applications & Pharmacology
-
Erectile Dysfunction & Andrology Models: Extensively utilized in PDE5-targeting studies focused on sexual function and vascular physiology .
-
Cardiovascular & Pulmonary Research: Enables exploration of vasodilatory response and pulmonary hypertension .
-
Pharmacokinetics: Oral bioavailability ~15%; protein binding ?95%; liver metabolism via CYP3A4; half-life of 4–5?h .
-
Toxicology: Non-carcinogenic up to 100 mg/kg/day in animals; high-dose exposures induced testicular and cardiovascular changes in rodents .
Safety Profile & Handling
-
Common Effects: Headache, flushing, nasal congestion, back pain, dizziness.
-
Serious Risks: Rare hypotension (especially with nitrates), QT prolongation, priapism .
-
Drug Interactions / Contraindications: Avoid co-administration with nitrates, alpha-blockers, or strong CYP3A4 inhibitors in research protocols .
-
Handling Instructions: Use PPE, store under recommended conditions, discard expired tablets per lab safety guidelines.
评价
目前还没有评价